Nanotechnology for Cancer Treatment: Possibilities and Limitations-Reference-Cited by-同舟云学术

Nanotechnology for Cancer Treatment: Possibilities and Limitations

Published:2013 Issue: Volume: Page:37-56
ISSN:
Container-title:Cancer Targeted Drug Delivery
language:
Short-container-title:

Author:

Nichols Joseph W.,Bae You Han

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4614-7876-8_2

Reference131 articles.

1. Wagner V, Dullaart A, Bock A-K, Zweck A (2006) Nat Biotechnol 24:1211–1217

2. Venditto VJ, & Szoka FC (2012). Cancer Nanomedicines: So Many Papers and So Few Drugs! Advanced drug delivery reviews, 65(1), 80–88. doi:10.1016/j.addr.2012.09.038

3. Flynn T, Wei C (2005) Nanomedicine 1:47–51

4. Wagner V, Husing B, Gaisser S, Bock A-K (2006) Nanomedicine: drivers for development and possible impacts. JRC Scientific and Technical Reports, Seville, pp 45–53

5. Feynman R (1960) Eng Sci 23:22–36

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron Sulfide Nanoparticles: Synthesis, Characterization, and Molecular Docking Studies of Its Interaction with Bovine Serum Albumin and Human Serum Albumin;BioNanoScience;2024-03-05

2. Polycaprolactone-based Nanocarriers Containing 5-fluorouracil as a Therapeutic Guided Drug Delivery Approach for Enhancing Anticancer Activity;Current Cancer Drug Targets;2023-08

3. Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment;Pharmaceutics;2021-01-24

4. Critical considerations for targeting colorectal liver metastases with nanotechnology;WIREs Nanomedicine and Nanobiotechnology;2019-09-30

5. Strategies to release doxorubicin from doxorubicin delivery vehicles;Journal of Drug Targeting;2017-08-13